Cosmo Full-Year Report 2019
Cosmo Pharmaceuticals N.V. reports Full-Year results for the year ended 31 December 2019.
Following the spread of coronavirus to the majority of countries in the world resulting in lockdowns and measures to contain the pandemic previously unseen Cosmo wishes to highlight the following:
Cosmo, as a pharmaceutical company, is exempt from business shutdown provisions in Italy.